Genomics

Chemogenomics company's library now consists of more than 250 drug signatures

Published in Heart Disease Weekly, October 19th, 2003

Iconix Pharmaceuticals, Inc., announced that its DrugMatrix library, the largest existing collection of experimental information of the effects of drug compounds on the genome, now consists of more than 250 highly specific, well-validated signatures.

Iconix CEO Jim Neal made the announcement concurrent with his speaking engagement at the 15th annual Life Sciences Partnering Meeting in San Francisco, sponsored by Burrill & Co.

Used in drug discovery, drug signatures are sets of biomarker genes associated with a specific compound, compound family, toxicology end-point, or efficacy readout. Each signature provides a prediction or indication of a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Heart Disease Weekly

Source: Heart Disease Weekly (2003-10-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry